barriers

Oxybenzone is a UV filter commonly used in tanning and skin protection agents. It is a derivative of benzophenone and is used as an endocrine disrupting chemical that penetrates the placental and blood-brain barriers. It impairs autophagy, alters epigenetic status and disrupts vitamin X-like receptor signaling in apoptotic neuronal cells.

Oxybenzone-D3 is a deuterium-labeled form of Oxybenzone. Commonly used as a UV filter in tanning and skin protection products, Oxybenzone (T0499) (Benzophenone 3) acts as an endocrine-disrupting chemical (EDC) that can cross both the placental and blood-brain barriers. It impairs autophagy, alters epigenetic states, and disrupts retinoid X receptor signaling in apoptotic neuronal cells.

Oxybenzone-13C6 is the 13C-labeled version of Oxybenzone. This compound, also known as Benzophenone 3, is commonly utilized as a UV filter in tanning and skin protection products. Oxybenzone (T0499) is an endocrine-disrupting chemical (EDC) capable of crossing the placental and blood-brain barriers. It impairs autophagy, alters the epigenetic state, and disrupts retinoid X receptor signaling in apoptotic neuronal cells.

XL-3158 is an orally active inhibitor of cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) with human cGAS IC50 of 11.1 μM and murine cGAS IC50 of 2.19 μM. It binds both allosteric and orthosteric sites, stabilizing the inactive closed conformation of the enzyme, thereby weakening cGAS interaction with DNA. By targeting phase separation, XL-3158 effectively penetrates cells, reduces intracellular cGAS local concentration through inhibition of aggregate formation, and shows no significant cytotoxicity at effective concentrations, making it suitable for subsequent cellular function experiments. XL-3158 overcomes species selectivity barriers, presenting a candidate drug for cGAS-dependent inflammatory diseases.

Hepoxilin A3 (HXA3) is a neutrophil chemoattractant synthesized through the activation of the PLA2-12-LOX pathway. It directs neutrophils to migrate across epithelial barriers to sites of infection, such as the alveolar space. In mouse models, levels of Hepoxilin A3 rise in tandem with neutrophil infiltration. It is used in research on inflammatory diseases like pneumonia and cystic fibrosis.

SV119 hydrochloride is a sigma-2 ligand with a Ki value of 5.2 nM. It enhances the efficient transport of drugs across cancer cell membranes. Combining dm-Erastin with SV119 hydrochloride successfully overcomes internalization barriers observed in pancreatic cancer while retaining the inherent antitumor activity of Erastin. Additionally, SV119 hydrochloride exhibits cytotoxic effects on triple-negative breast cancer (TNBC) cells and induces apoptosis (apoptosis).

ANG1005 is a brain-penetrating peptide-agent conjugate comprising a taxane derivative that features three paclitaxel molecules covalently bonded to Angiopep-2. This design facilitates crossing of the blood-brain and blood-cerebrospinal barriers, with subsequent penetration of malignant cells through the low-density lipoprotein receptor-related protein (LRP1) transport system [1] [2] [3].

SWELYYPLRANL-NH2 TFA acts as an antagonist to both E-cadherin and N-cadherin, with inhibitory effects on phage clone binding to E- or N-cad/Fc chimeric proteins, exhibiting IC50 values of 0.7 μM and 0.09 μM, respectively. Additionally, it disrupts cell aggregation and is utilized to enhance drug delivery by increasing the permeability of epithelial and endothelial barriers [1].

SWELYYPLRANL-NH2 is a dual antagonist of E-cadherin and N-cadherin, effectively inhibiting the binding of phage clones to both E-cad/Fc and N-cad/Fc chimeric proteins with IC50 values of 0.7 μM and 0.09 μM, respectively. This compound also impedes cell aggregation and has potential applications in enhancing drug delivery by increasing epithelial and endothelial permeability barriers [1].

4-FPBUA, a semi-synthetic analog of lichen acid, enhances the functionality of cell-based blood-brain barriers (BBB) and increases the transport of β-amyloid (Aβ) in monolayer cells. Additionally, it acts as an inhibitor of mTOR, enhancing cellular autophagy (Autophagy) which can reverse BBB disruption in vivo, making it relevant for research in Alzheimer's disease.

RG-6333 is a bispecific agonist targeting CD19 and CD28. It specifically identifies and binds to the CD19 antigen present on the surface of malignant B cells, effectively targeting tumor cells. By engaging with CD28, RG-6333 activates T cells, overcoming activation barriers and boosting antitumor immunity. RG-6333 is applicable for research in relapsed/refractory non-Hodgkin lymphoma.

Linoleic acid-D5 is the deuterated form of Linoleic acid. Linoleic acid (T4P2931) is a common polyunsaturated fatty acid (PUFA) found in vegetable oils, nuts, and seeds. It is part of membrane phospholipids, contributing as a structural component to maintain epidermal transdermal water barriers. Linoleic acid (T4P2931) can induce damage to erythrocytes and hemoglobin through oxidation.

Oxybenzone (Standard) is the standard substance of Oxybenzone, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Oxybenzone is a UV filter commonly used in tanning and skin protection agents. It is a derivative of benzophenone and is used as an endocrine disrupting chemical that penetrates the placental and blood-brain barriers. It impairs autophagy, alters epigenetic status and disrupts vitamin X-like receptor signaling in apoptotic neuronal cells.